A squamous cell carcinoma of the tonsils is an aggressive and metastatic tumor that arises from the epithelial cells of the tonsils. The epithelium is the cellular covering of all of the internal and external surfaces of the body, protecting the organs, inner cavities and outer surfaces of the body in a continuous layer of multi-layered tissue. Tonsillar carcinoma in Germany from 23.2% in the years between 2005 and 2007 to 58.6% between 2010 and 2012. The majority (80.2%) of p16-positive patients presented with early T-category tumor but most of these (79.0%) had also lymph node metastases. The p16-positive cases also had a very high rate of occult cervical metastases (68.7%). Nevertheless, p16-positive patients had excellent oncologic results and could be considered for de-escalation of treatment.
The cancer treatment options available in non-Hodgkin’s lymphoma are radiotherapy and chemotherapy. If the cancerous tumor is highly localised to the tonsils or head and neck region, then the tonsil cancer treatment of choice is radiotherapy and is very effective. More advanced tonsil cancer will require systemic cancer treatment with chemotherapy, but may also include radiotherapy as part of the cancer treatment regime. New techniques introduced to reduce complications, making Tonsil cancer a safer operation for more people than ever before. Further research is being conducted to determine the best surveillance interval to monitor these cysts.